Subscribe to RSS - diabetes

diabetes

FDA clears Omnipod DASH

 - 
06/06/2018

BILLERICA, Mass. – Insulet Corp. has received clearance from the U.S. Food and Drug Administration for its Omnipod DASH Insulin Management System. The Omnipod DASH features an easy-to-read, touch-screen PDM; user-friendly steps to manage basal rates; and a food library.

ADA: Improve insulin access, affordability

 - 
05/31/2018

ARLINGTON, Va. – The American Diabetes Association on May 24 released a public policy statement outlining both long- and short-term recommendations for improving insulin access and affordability.

Inolife primes ADW to distribute Inojex

 - 
04/17/2018

TORONTO – Inolife R&D has entered into a letter of intent with ADW Diabetes for the distribution of its Inojex, a patented and FDA-cleared needle-free injection device.

Softgait makes it easy to add new business

 - 
01/23/2018

FLETCHER, N.C. – A new tool that connects DME providers with a nationwide network of certified shoe fitters aims to help providers kick-start a therapeutic shoe business without having to incur a lot of expense, says Marcus Suess.

One Drop knocks down barriers to diabetes management

 - 
01/23/2018

NEW YORK – One Drop’s primary goal has always been to give people with diabetes a place to collect all of the data that matters to them, says Rachel Sanchez, marketing associate.

Second CGM receives Medicare approval

 - 
01/09/2018

ABBOTT PARK, Ill. – The FreeStyle Libre System is the second continuous glucose monitoring system approved for Medicare coverage. The Abbott-manufactured system requires no user calibration, reading glucose levels via a sensor worn on the upper arm.

It's a diabetes thing

 - 
Tuesday, November 14, 2017

Last week, I mentioned to editor Liz that I needed to leave early for a dentist appointment.

“It seems like you’ve been going to the dentist a lot,” she said.

“Yep. I go four times a year now,” I replied.

“Is that a diabetes thing?” she asked.

CMS to update definitions for shoe inserts

 - 
11/07/2017

WASHINGTON – CMS has proposed revising the definitions of custom fabricated and therapeutic inserts in Appendix C of the DMEPOS Quality Standards to account for new technology.

Patient self-management key to diabetes

 - 
10/20/2017

Among the patient population with chronic illnesses, diabetes is the most common catalyst and comorbidity, which makes it one of the most complex and important disorders facing providers. And its growth, gradually rising for decades, continues unabated.

Ascensia, Dexcom bundle diabetes products

 - 
07/19/2017

PARSIPPANY, N.J. – Ascensia Diabetes Care and Dexcom have hammered out a commercial agreement that they expect to increase access to the Dexcom G5 continuous glucose monitoring system.

Pages